Correlation Between Amerisourcebergen and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amerisourcebergen and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amerisourcebergen and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amerisourcebergen Corp and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Amerisourcebergen and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amerisourcebergen with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amerisourcebergen and CRISPR Therapeutics.

Diversification Opportunities for Amerisourcebergen and CRISPR Therapeutics

  Correlation Coefficient

Significant diversification

The 3 months correlation between Amerisourcebergen and CRISPR is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Amerisourcebergen Corp and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Amerisourcebergen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amerisourcebergen Corp are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Amerisourcebergen i.e., Amerisourcebergen and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Amerisourcebergen and CRISPR Therapeutics

Considering the 90-day investment horizon Amerisourcebergen Corp is expected to under-perform the CRISPR Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Amerisourcebergen Corp is 2.38 times less risky than CRISPR Therapeutics. The stock trades about -0.19 of its potential returns per unit of risk. The CRISPR Therapeutics AG is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  6,501  in CRISPR Therapeutics AG on July 9, 2022 and sell it today you would lose (336.00)  from holding CRISPR Therapeutics AG or give up 5.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
ValuesDaily Returns

Amerisourcebergen Corp  vs.  CRISPR Therapeutics AG

 Performance (%) 
Amerisourcebergen Corp 
Amerisourcebergen Performance
0 of 100
Over the last 90 days Amerisourcebergen Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, Amerisourcebergen is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Amerisourcebergen Price Channel

CRISPR Therapeutics 
CRISPR Performance
0 of 100
Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm insiders.

CRISPR Price Channel

Amerisourcebergen and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   

Pair Trading with Amerisourcebergen and CRISPR Therapeutics

The main advantage of trading using opposite Amerisourcebergen and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amerisourcebergen position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
Amerisourcebergen vs. Amazon Inc
The idea behind Amerisourcebergen Corp and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
CRISPR Therapeutics vs. Ashted Group Plc
CRISPR Therapeutics vs. Hertz Global Holdings
CRISPR Therapeutics vs. A M E
CRISPR Therapeutics vs. McGrath RentCorp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals